NCT00218114View on ClinicalTrials.gov

Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

February 18, 2005

Study Completion Date

February 18, 2005

Conditions
Attention Deficit and Disruptive Behavior DisordersMarijuana Abuse
Interventions
DRUG

Divalproex Sodium

Participants are titrated over 2 weeks, as tolerated to 10 mgs / pound, and blood levels are checked to determine that the blood level is between 50-110 micrograms / ml.

DRUG

Placebo

Participants will be on matching placebo.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00218114 - Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults | Biotech Hunter | Biotech Hunter